{"SLR NAME":"Efficacy and safety of corticosteroid in treatment of patients with COVID-19: a systematic review and meta-analysis","References":[{"title1":"Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [in Chinese]"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [e-pub ahead of print]. N Engl J Med doi: 10.1056/NEJMoa2001282, Accessed March 15, 2020."},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"First cases of COVID-19 in heart transplantation From China"},{"title3":"COVID-19: yet another coronavirus challenge in transplantation"},{"title3":"Epidemiological and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: a descriptive survey report"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus"},{"title3":"Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China [e-pub ahead of print]. Clin Infect Dis doi: 10.1093/cid/ciaa248, Accessed March 15, 2020."},{"title3":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [e-pub ahead of print]. JAMA Intern Med doi: 10.1001/jamainternmed.2020.0994, Accessed March 15, 2020."},{"title3":"Mehta P, McAuley DF, Brown M,et al. COVID-19: consider cytokine storm syndromes and immunosuppression [e-pub ahead of print]. Lancet doi: 10.1016/S0140-6736(20)30628-0, Accessed March 15, 2020."}]},{"title2":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[]},{"title2":"Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in Severe COVID-19 patients","References":[]},{"title2":"Coronavirus disease 2019 treatment: a review of early and emerging options","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Involving antimicrobial stewardship programs in COVID-19 response efforts: all hands on deck"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"},{"title3":"First newborn baby to receive experimental therapies survives Ebola virus disease"},{"title3":"First 12 patients with coronavirus disease 2019 (COVID-19) in the United States."},{"title3":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19"},{"title3":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Clinical pharmacokinetics of slow-acting antirheumatic drugs"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial"},{"title3":"Of chloroquine and COVID-19"},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"The diagnosis and treatment guide of COVID-19 pneumonia caused by new coronavirus infection 7th Edition, published March 3rd, 2020."},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR"},{"title3":"The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019"},{"title3":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children"},{"title3":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus"},{"title3":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial"},{"title3":"Efficacy and safety of nitazoxanide in addition to standard of care for the treatment of severe acute respiratory illness"},{"title3":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome"},{"title3":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells"},{"title3":"Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells"},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: a multicenter observational study"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Convalescent plasma as a potential therapy for COVID-19"},{"title3":"Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes"},{"title3":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Broad spectrum antiviral agent niclosamide and its therapeutic potential"},{"title3":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19"},{"title3":"XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial"}]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Surviving sepsis campaign: guidelines on the management of critically Ill adults with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China."},{"title3":"Conflicts of interest disclosure forms and management in critical care clinical practice guidelines."},{"title3":"Understanding conflicts of interest."},{"title3":"GRADE guidelines: 2. Framing the question and deciding on important outcomes."},{"title3":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers."},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations."},{"title3":"GRADE guidelines: 3. Rating the quality of evidence."},{"title3":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations."},{"title3":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes."},{"title3":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT."},{"title3":"Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks."},{"title3":"Control measures for severe acute respiratory syndrome (SARS) in Taiwan."},{"title3":"Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure."},{"title3":"SARS: ventilatory and intensive care."},{"title3":"Particle removal efficiency of the portable HEPA air cleaner in a simulated hospital ward."},{"title3":"Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis."},{"title3":"N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial."},{"title3":"Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial."},{"title3":"A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers."},{"title3":"Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers."},{"title3":"A randomized clinical trial of three options for N95 respirators and medical masks in health workers."},{"title3":"Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis."},{"title3":"Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic."},{"title3":"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature."},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review."},{"title3":"Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation: a Cochrane Systematic Review."},{"title3":"Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation."},{"title3":"Should the Glidescope video laryngoscope be used first line for all oral intubations or only in those with a difficult airway? A review of current literature."},{"title3":"Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia."},{"title3":"Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests."},{"title3":"Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus."},{"title3":"Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China."},{"title3":"Laboratory diagnosis of SARS."},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China."},{"title3":"Incorporating Dynamic Assessment of Fluid Responsiveness Into Goal-Directed Therapy: A Systematic Review and Meta-Analysis."},{"title3":"Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids?"},{"title3":"Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: A meta-analysis."},{"title3":"Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial."},{"title3":"Lower versus higher fluid volumes during initial management of sepsis: a systematic review with meta-analysis and trial sequential analysis."},{"title3":"Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis."},{"title3":"Mortality after fluid bolus in African children with severe infection."},{"title3":"Colloids versus crystalloids for fluid resuscitation in critically ill people."},{"title3":"Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children."},{"title3":"Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure."},{"title3":"Vasopressors for hypotensive shock."},{"title3":"Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock."},{"title3":"Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis."},{"title3":"Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock."},{"title3":"Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial."},{"title3":"Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure."},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis."},{"title3":"Corticosteroid therapy for sepsis: a clinical practice guideline."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"The Search for Optimal Oxygen Saturation Targets in Critically Ill Patients: Observational Data From Large ICU Databases."},{"title3":"Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis."},{"title3":"Oxygen therapy for acutely ill medical patients: a clinical practice guideline."},{"title3":"Conservative Oxygen Therapy during Mechanical Ventilation in the ICU."},{"title3":"Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome."},{"title3":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure."},{"title3":"The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis."},{"title3":"Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials."},{"title3":"High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis."},{"title3":"Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada."},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation."},{"title3":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial."},{"title3":"Staff safety during emergency airway management for COVID-19 in Hong Kong."},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome."},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection."},{"title3":"Noninvasive Oxygenation Strategies in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials."},{"title3":"Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis."},{"title3":"Noninvasive versus invasive mechanical ventilation for immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis."},{"title3":"Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review."},{"title3":"Noninvasive ventilation for patients with hypoxemic acute respiratory failure."},{"title3":"Ventilator-induced lung injury."},{"title3":"Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features."},{"title3":"Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease."},{"title3":"Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure."},{"title3":"Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask."},{"title3":"Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome."},{"title3":"A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial."},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome."},{"title3":"Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients."},{"title3":"Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome."},{"title3":"(The application of low tidal volume pressure-controlled ventilation in patients with acute respiratory distress syndrome)."},{"title3":"An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome."},{"title3":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016."},{"title3":"Patient-ventilator asynchrony during assisted mechanical ventilation."},{"title3":"Optimal plateau pressure for patients with acute respiratory distress syndrome: a protocol for a systematic review and meta-analysis with meta-regression."},{"title3":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome."},{"title3":"Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial."},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis."},{"title3":"Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis."},{"title3":"Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Comparison of two fluid-management strategies in acute lung injury."},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study."},{"title3":"Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome."},{"title3":"The prone position eliminates compression of the lungs by the heart."},{"title3":"Lung ventilation and perfusion in prone and supine postures with reference to anesthetized and mechanically ventilated healthy volunteers."},{"title3":"Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Prone position for acute respiratory failure in adults."},{"title3":"The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and metaanalysis."},{"title3":"The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: updated study-level meta-analysis of 11 randomized controlled trials."},{"title3":"Enteral feeding in the critically ill: comparison between the supine and prone positions: a prospective crossover study in mechanically ventilated patients."},{"title3":"Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines."},{"title3":"Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient."},{"title3":"New UK guidelines for the management of adult patients with ARDS."},{"title3":"Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome."},{"title3":"Formal guidelines: management of acute respiratory distress syndrome."},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials."},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome."},{"title3":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults."},{"title3":"Lung recruitment in patients with the acute respiratory distress syndrome."},{"title3":"Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial."},{"title3":"Clinical efficacy and safety of recruitment maneuver in patients with acute respiratory distress syndrome using low tidal volume ventilation: a multicenter randomized controlled clinical trial."},{"title3":"Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome."},{"title3":"Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP). A Phase II, Multicenter Randomized Controlled Clinical Trial."},{"title3":"Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome."},{"title3":"Lung Recruitment Maneuvers for Adult Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus."},{"title3":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome."},{"title3":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial."},{"title3":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis."},{"title3":"Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation."},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome."},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression."},{"title3":"Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China."},{"title3":"Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza."},{"title3":"Pharmacological agents for adults with acute respiratory distress syndrome."},{"title3":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial."},{"title3":"Effect of Intravenous Interferon beta-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China."},{"title3":"Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis."},{"title3":"Reevaluating the Role of Corticosteroids in Septic Shock: An Updated Meta-Analysis of Randomized Controlled Trials."},{"title3":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome."},{"title3":"Systemic Corticosteroid Therapy May Delay Viral Clearance in Patients with Middle East Respiratory Syndrome Coronavirus Infection."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients."},{"title3":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa."},{"title3":"Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study."},{"title3":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States."},{"title3":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States."},{"title3":"Do specific virus-bacteria pairings drive clinical outcomes of pneumonia?"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis,"},{"title3":"The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study."},{"title3":"Acetaminophen for Fever in Critically Ill Patients with Suspected Infection."},{"title3":"Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group."},{"title3":"The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group."},{"title3":"Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling."},{"title3":"Effects of lornoxicam on the physiology of severe sepsis."},{"title3":"Randomized trial of the effect of intravenous paracetamol on inflammatory biomarkers and outcome in febrile critically ill adults."},{"title3":"Fever control using external cooling in septic shock: a randomized controlled trial."},{"title3":"Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: a pilot randomized clinical trial."},{"title3":"Body temperature control in patients with refractory septic shock: too much may be harmful."},{"title3":"Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial."},{"title3":"Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial."},{"title3":"Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study."},{"title3":"Adverse effects of human immunoglobulin therapy."},{"title3":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial."},{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection."},{"title3":"The convalescent sera option for containing COVID-19."},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection."},{"title3":"SARS: systematic review of treatment effects."},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection."},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Successful treatment of avian influenza with convalescent plasma."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta-analysis."},{"title3":"Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia."},{"title3":"Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea."},{"title3":"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial."},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset."},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial."},{"title3":"Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection."},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection."},{"title3":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics."},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin."},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques."},{"title3":"Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."},{"title3":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)."},{"title3":"Of chloroquine and COVID-19."},{"title3":"Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection."},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies."},{"title3":"(Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia)."},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19."},{"title3":"Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial."},{"title3":"Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes."},{"title3":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial."},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome."},{"title3":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients."},{"title3":"Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials."},{"title3":"Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials."},{"title3":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial."},{"title3":"Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness."}]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds."},{"title3":"Small molecules targeting severe acute respiratory syndrome human coronavirus."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset."},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome."},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen."},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) home page ()."},{"title3":"Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection."},{"title3":"Coronavirus disease (COVID-2019) R&amp;D. Geneva: World Health Organization ()."},{"title3":"National Early Warning Score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. London: Royal College of Physicians, 2017 ()."},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study."},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data."},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09."},{"title3":"Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients."},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus."}]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia","References":[{"title3":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]"},{"title3":"Use of corticosteroids in treating infectious diseases"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report"}]},{"title2":"The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death","References":[]},{"title2":"Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","References":[{"title3":"Hospital deaths in patients with sepsis from 2 independent cohorts"},{"title3":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care"},{"title3":"2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome"},{"title3":"Effectiveness of a hospital-wide educational programme for infection control to reduce the rate of health-care associated infections and related sepsis (ALERTS):methods and interim results [in German]"},{"title3":"The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure"},{"title3":"The Logistic Organ Dysfunction System: a new way to assess organ dysfunction in the intensive care unit"},{"title3":"Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement"},{"title3":"The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study"},{"title3":"The inconsistency of &quot;optimal&quot; cutpoints obtained using two criteria based on the receiver operating characteristic curve"},{"title3":"Prediction of critical illness during out-of-hospital emergency care"},{"title3":"APACHE:Acute Physiology and Chronic Health Evaluation: a physiologically based classification system"},{"title3":"Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited"},{"title3":"Cronbach's alpha"},{"title3":"Convergent and discriminant validation by the multitrait-multimethod matrix"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"Building multivariable regression models with continuous covariates in clinical epidemiology:with an emphasis on fractional polynomials"},{"title3":"Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics"},{"title3":"Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012"},{"title3":"Consensus on circulatory shock and hemodynamic monitoring: task force of the European Society of Intensive Care Medicine"},{"title3":"Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values"},{"title3":"The meaning and use of the area under a receiver operating characteristic (ROC) curve"},{"title3":"Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program"},{"title3":"Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia"},{"title3":"Risk-adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system"},{"title3":"Systemic inflammatory response syndrome criteria in defining severe sepsis"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Comparison of trends in sepsis incidence and coding using administrative claims vs objective clinical data"},{"title3":"Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule"},{"title3":"Concept of PIRO as a new conceptual framework to understand sepsis"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the Angus implementation of the International Consensus Conference definition of severe sepsis"},{"title3":"Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study"}]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"A framework for rationing ventilators and critical care beds during the COVID-19 pandemic","References":[]},{"title2":"Critical supply shortages - the need for ventilators and personal protective equipment during the Covid-19 pandemic","References":[]},{"title2":"Corticosteroid therapy for critically Ill patients with middle east respiratory syndrome","References":[]},{"title2":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","References":[{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Management and prevention of SARS in China"},{"title3":"Medical treatment of viral pneumonia including SARS in immunocompetent adult"},{"title3":"SARS: pharmacotherapy"},{"title3":"High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome"},{"title3":"Nosocomial infections and nosocomial pneumonia"},{"title3":"Chinese Medical Association. Guidelines for management of atypical pneumonia (SARS)"},{"title3":"Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test"},{"title3":"A preliminary study of serum antibody level in SARS patients"},{"title3":"Severe acute respiratory syndrome (SARS): a challenge for diagnosis and treatment"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"High dose methylprednisolone in a porcine model of ARDS induced by endotoxemia"},{"title3":"Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"High dose corticosteroids in patients with the adult respiratory distress syndrome"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome"},{"title3":"Respiratory and cadiovascular management of septic ALI-ARDS and shock"},{"title3":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Prolonged disturbances ofin vitrocytokine production in patients with severe acute respiratory syndrome treated with ribavirin and steroids"},{"title3":"Report on the investigation of lower extremity osteonecrosis with magnetic resonance imaging in recovered severe acute respiratory syndrome in Guangzhou"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence"},{"title3":"Avascular necrosis of bone in severe acute respiratory syndrome"}]},{"title2":"Factors associated with prolonged viral RNA shedding in patients with COVID-19","References":[{"title3":"Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study"},{"title3":"Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in coronavirus disease 2019: a case control study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Viral load of SARS-CoV-2 in clinical samples"},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"},{"title3":"Factors associated with prolonged viral RNA shedding in patients with COVID-19 [published online ahead of print April 9, 2020]"},{"title3":"Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]}]},{"title1":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19","References":[{"title2":"Clinical progression of patients with COVID-19 in Shanghai, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: Implication for infection prevention and control measures"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Note from the editors: world health organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern"},{"title3":"World Health Organization. Coronavirus dieases 2019 (COVID-19) situation report - 40 2020[cited 2020 Mar 1st]. Available from:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf?sfvrsn=7203e653_2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"A novel coronavirus from patients with pneumonia in China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, people's republic of China"},{"title3":"Clinical presentation and outcomes of middle east respiratory syndrome in the republic of Korea"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated sars pneumonia: a prospective study"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"National Health Commission of the People's Republic of China. The 5th trial version of Diagnosis and Treatment Scheme for Pneumonitis with 2019-nCoV Infection (In Chinese). [cited 2020 Mar 20]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml (2020).","References":[]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients","References":[]},{"title2":"Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome","References":[]},{"title2":"Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia","References":[]},{"title2":"Retrospective study of low-to-moderate dose glucocorticoids on viral clearance in patients with novel coronavirus pneumonia","References":[]}]},{"title1":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19","References":[{"title2":"Clinical progression of patients with COVID-19 in Shanghai, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: Implication for infection prevention and control measures"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Note from the editors: world health organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern"},{"title3":"World Health Organization. Coronavirus dieases 2019 (COVID-19) situation report - 40 2020[cited 2020 Mar 1st]. Available from:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf?sfvrsn=7203e653_2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"A novel coronavirus from patients with pneumonia in China"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, people's republic of China"},{"title3":"Clinical presentation and outcomes of middle east respiratory syndrome in the republic of Korea"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated sars pneumonia: a prospective study"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"National Health Commission of the People's Republic of China. The 5th trial version of Diagnosis and Treatment Scheme for Pneumonitis with 2019-nCoV Infection (In Chinese). [cited 2020 Mar 20]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml (2020).","References":[]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients","References":[]},{"title2":"Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome","References":[]},{"title2":"Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia","References":[]},{"title2":"Retrospective study of low-to-moderate dose glucocorticoids on viral clearance in patients with novel coronavirus pneumonia","References":[]}]},{"title1":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Text Transcription of Press Conference on February 11, 2020 (in Chinese)","References":[]},{"title2":"Transmissibility of 2019-nCoV","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)","References":[]},{"title2":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China","References":[]},{"title2":"Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS)","References":[]},{"title2":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study","References":[{"title3":"Coronavirus diversity, phylogeny and interspecies jumping"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"Bats as 'special' reservoirs for emerging zoonotic pathogens"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"Trimmomatic: a flexible trimmer for Illumina sequence data"},{"title3":"The diploid genome sequence of an Asian individual"},{"title3":"SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data"},{"title3":"Improved metagenomic analysis with Kraken 2"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"ORF8-related genetic evidence for Chinese horseshoe bats as the source of human severe acute respiratory syndrome coronavirus"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Global epidemiology of bat coronaviruses"},{"title3":"Bats and their virome: an important source of emerging viruses capable of infecting humans"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China"},{"title3":"Origin and evolution of pathogenic coronaviruses"}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection is Suspected","References":[]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]}]},{"title1":"Adjuvant corticosteroid therapy for critically ill patients with COVID-19","References":[{"title2":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;6736(20):30566-73.","References":[]},{"title2":"Organization WH: Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. In: World Health Organization; 2020.","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"The central role of the propensity score in observational studies for causal effects","References":[]},{"title2":"Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores","References":[]}]}]}